Latest Publications

Share:

British Columbia and Prince Edward Island Sign Pharmacare Agreement with Canada Under New Pharmacare Act

On February 27, 2025, the Government of Canada and Manitoba signed the first national pharmacare agreements under Canada’s Bill C-64, An Act respecting pharmacare (the “Pharmacare Act”), which received royal assent on October...more

Health Canada Consults on Pathway for Health Products Containing CBD

Health Canada recently announced that it is exploring a regulatory pathway that would allow products containing cannabidiol (“CBD”) to be purchased without a prescription. Under the current regulatory scheme, all health...more

Canada and Manitoba Sign Pharmacare Agreement Under New Pharmacare Act

Canada’s Bill C-64, An Act respecting pharmacare (the “Pharmacare Act”) received royal assent on October 10, 2024 and established a framework for national pharmacare. On February 27, 2025, the Hon. Mark Holland, Canada’s...more

New Regulatory Amendments Under the Food and Drugs Act: Addressing Drug and Medical Device Shortages in Canada

On December 28, 2024, Health Canada published a regulatory proposal in the Canada Gazette, Part I, Volume 158, Number 52, introducing amendments to the Food and Drug Regulations, CRC, c 870 and the Medical Devices...more

Federal Government Announces Policy on Canada Health Act Status of Payments to Regulated Healthcare Professionals Providing...

Friday, the Federal Government issued correspondence to the provinces and territories regarding its newly introduced Canada Health Act Services Policy. As set out in this correspondence from the Minister of Health, the CHA...more

Environmental Regulatory Developments: Are You Ready for PFAS Reporting?

The Canadian government, through Environment and Climate Change Canada (“ECCC”), issued a notice (the “Notice”) under the Canadian Environmental Protection Act, 1999 (“CEPA”), outlining critical reporting requirements for...more

The Pharmacare Act Receives Royal Assent

On October 10, 2024, Canada’s Bill C-64, An Act respecting pharmacare (the “Pharmacare Act”) received Royal Assent. This legislation establishes a framework for a national universal pharmacare system, aiming to enhance the...more

Health Canada: Changes to the Cosmetic Regulations

The Regulations Amending Certain Regulations Concerning the Disclosure of Cosmetic Ingredients (SOR/2024-63) (the “Amended Cosmetic Regulations), published on April 24, 2024, took effect on October 9th (with the exception of...more

Regulatory Amendments Impacting Drug and Medical Device Recalls Coming Into Force

On December 17, 2024, recent amendments to the Food and Drug Regulations (FDR) and the Medical Devices Regulations (MDR) relating to the recall of drugs and medical devices will come into force....more

Ontario Issues Call for Applications for Community Surgical and Diagnostic Centers

Ontario has (finally!) made the call to community surgical and diagnostic centers for applications for new licences under the Integrated Community Health Services Centres Act, 2023 (the Act) to provide MRI and CT...more

10 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide